Kirsten Canté-Barrett
Leiden University Medical Center(NL)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Immune Cell Function and Interaction, T-cell and B-cell Immunology, CAR-T cell therapy research
Most-Cited Works
- → ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia(2014)272 cited
- → Lymphocyte calcium signaling from membrane to nucleus(2005)176 cited
- → Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy?(2021)150 cited
- → T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies(2020)141 cited
- → IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study(2016)102 cited
- → Myocyte enhancer factor 2C in hematopoiesis and leukemia(2013)93 cited
- → MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia(2016)90 cited
- → Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors(2013)87 cited
- → ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling(2015)87 cited
- → PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events(2014)81 cited